January 31, 2017
Lilly’s Q4 net income up 61%
Driven by new products, including Trulicity, Cyramza, Jardiance and Taltz, Lilly’s volume-driven significant growth in 2016.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Q4
January 27, 2017
AbbVie’s fourth quarter earnings down, but generates $809M more than 2015 full year
The fourth quarter was a continuation of the strong performance and business momentum AbbVie has delivered since becoming an independent company in 2013.
January 27, 2017
French Poxel exectedly falls short on revenue in Q4 2016
French drugmaker focused on diabetes treatments Poxel, said it expectedly did not generate meaningful revenues in the fourth quarter of 2016, but it is on track for developing two of its programs.
January 27, 2017
BMS posts Q4 net profit, revenues driven by Opdivo sales up
Bristol-Myers Squib on Thursday posted fourth quarter net earnings of $1.1 billion, driven ly by increased sales of Opdivo and Eliquis.
January 25, 2017
Novartis 2016 full year net income down 6%
Novartis delivered a solid performance in 2016, absorbing Gleevec US loss of exclusivity while investing in key launches and the Alcon Division turnaround